Bedaquiline fumarate, also known as R403323 or TMC207 fumarate, is a potent diarylquinoline antibiotic that primarily targets ATP synthase. This mechanism of action makes it highly effective for treating Mycobacterium tuberculosis infections, including difficult-to-treat multidrug-resistant (MDR) strains. It is intended for research use only.
- Antibiotic mechanism: Functions as a bacterial inhibitor by targeting ATP synthase
- Antituberculosis activity: Effective against Mycobacterium tuberculosis infections, including multidrug-resistant strains
- In vitro efficacy: Inhibits growth of TDR M. tuberculosis strains and shows high activity against Mycobacterium avium
- Research use: Intended for laboratory research and development